Astragalus Polysaccharide Nanoemulsion: A Promising Adjuvant for Foot‐And‐Mouth Disease Virus‐Like Particle Vaccines
Transboundary and Emerging Diseases · 2025
DOI: 10.1155/tbed/6693841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2025. Verfasst von Xiaoni Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Insti…. Hauptthemen laut MEDLINE: Foot-and-Mouth Disease, Foot-and-Mouth Disease Virus, Polysaccharides, Astragalus Plant. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vaccine immunization is the most cost‐effective way for preventing infectious diseases, and the development of safe and effective adjuvants is crucial for ensuring vaccine efficacy. Due to the advantages of high safety profile, excellent stability, and significant immune‐enhancing properties, nanoemulsions have become widely used adjuvants in animal vaccines. In this study, a novel astragalus polysaccharide nanoemulsion (APSN) was developed using pseudo‐ternary phase diagram method combined with phase inversion technique. The resulting nanoemulsion exhibited a hydrated diameter of approximately 78.82 nm, with favorable stability and biocompatibility. A vaccine based on FMDV virus‐like particles (VLPs) was formulated using APSN as an adjuvant and was used to immunize mice and pigs. Mouse immunization results demonstrated that APSN significantly enhanced the levels of specific antibodies, IgG1, IgG2a, IFN‐γ, and IL‐4 induced by FMDV VLPs. Comparing with ISA‐206, immunization in pigs showed that APSN paired with FMDV VLPs induced higher levels of specific antibodies, neutralizing antibodies, IL‐1β, IL‐4, and IFN‐γ. The above results indicate that APSN is a new type of nanoemulsion adjuvant with strong potential to enhance vaccine immunogenicity, contributing valuable insights to the development of nanoadjuvant‐based vaccine formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
- School of Chemical Engineering, Lanzhou City University, Lanzhou 730070, China.
- College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.
- Yunnan Tropical and Subtropical Animal Virus Diseases Laboratory, Yunnan Animal Science and Veterinary Institute, Kunming, Yunnan, China.
ORCID-Profile: Shiqi Sun, Huichen Guo
Zitieren
APA
Shi, X., Teng, Z., Yang, K., Song, H., Zhang, Y., Tan, S., Dong, H., Sun, S., Ding, Y., & Guo, H. (2025). Astragalus Polysaccharide Nanoemulsion: A Promising Adjuvant for Foot‐And‐Mouth Disease Virus‐Like Particle Vaccines. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/6693841
Vancouver
Shi X, Teng Z, Yang K, Song H, Zhang Y, Tan S, et al. Astragalus Polysaccharide Nanoemulsion: A Promising Adjuvant for Foot‐And‐Mouth Disease Virus‐Like Particle Vaccines. Transboundary and Emerging Diseases. 2025. doi:10.1155/tbed/6693841
BibTeX
@article{Shi2025,
author = {Shi, Xiaoni and Teng, Zhidong and Yang, Kun and Song, Hetao and Zhang, Yun and Tan, Shuzhen and Dong, Hu and Sun, Shiqi and Ding, Yaozhong and Guo, Huichen},
title = {Astragalus Polysaccharide Nanoemulsion: A Promising Adjuvant for Foot‐And‐Mouth Disease Virus‐Like Particle Vaccines},
journal = {Transboundary and Emerging Diseases},
year = {2025},
doi = {10.1155/tbed/6693841}
}
EUVIMED